1,3-Dipolar cycloaddition route to novel isoxazole-type derivatives related to combretastatin A-4

Tetrahedron Letters

Volumn 45, Issue 17, 2004, Pages 3359-3362

  Kaffy, Julia ^a   Monneret, Claude ^a   Mailliet, Patrick ^b   Commerçon, Alain ^b   Pontikis, Renée ^a  

^a INSTITUT CURIE   (France)

^b SANOFI   (France)

Author keywords

1,3 Dipolar cycloaddition; Combretastatin; Nitrile oxide

Indexed keywords

ALDOXIME; COMBRETASTATIN A4; HETEROCYCLIC COMPOUND; HYPOCHLORITE SODIUM; ISOXAZOLE DERIVATIVE; NITRILE; OXIDE; PHENYL GROUP; STILBENE DERIVATIVE;

ARTICLE; CYCLOADDITION; DRUG SYNTHESIS; ISOMERISM; METHODOLOGY;

EID: 1842637466     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2004.03.020     Document Type: Article

References (27)

1. Pettit G.R., Singh S.B., Niven M.L., Hamel E., Schmidt J.M. J. Nat. Prod. 50:1987;119-131.
2. Pettit G.R., Singh S.B., Boyd M.R., Hamel E., Pettit R.K., Schmidt J.M., Hogan F. J. Med. Chem. 38:1995;1666-1672.
3. McGown A.T., Fox B.W. Anti-Cancer Drug Des. 3:1989;249-254.
4. Griggs J., Metcalfe J.C., Hesketh R. Lancet Oncol. 2:2001;82-87. and references cited therein.
5. Galbraith S.M., Maxwel R.J., Lodge M.A., Tozer G.M., Wilson J., Taylor N.J., Stirling J.J., Sena L., Padhani A.R., Rustin G.S. J. Clin. Oncol. 15:2003;2831-2842.
6. For a review, see: Nam N.-H. Curr. Med. Chem. 10:2003;1697-1722.
7. Wang L., Woods K.W., Li Q., Barr K.L., McCroskey R.W., Hannick S.M., Gherke L., Credo R.B., Hui Y.-H., Marsh K., Warner R., Lee J.Y., Zielinski-Mozng N., Frost D., Rosenberg S.H., Sham H.L. J. Med. Chem. 45:2002;1697-1711.
8. Kim Y., Nam N.-H., You Y.-J., Ahn B.-Z. Bioorg. Med. Chem. Lett. 12:2002;719-722.
9. Grünanger P., Vita-Finzi P. Isoxazoles, Part I. Chemistry of Heterocyclic Compounds. Vol. 49:1991;John Wiley, New York.
10. Carruthers W. Cycloaddition Reactions in Organic Synthesis. Tetrahedron Organic Chemistry Series. Vol. 8:1990;Pergamon.
11. Gothelf K.V., Jorgensen K.A. Chem. Rev. 98:1998;263-269.
12. Grundmann C. Synthesis. 1970;344-359.
13. Huisgen R., Cristl M. Chem. Ber. 106:1973;3345-3367.
14. Lee G.A. Synthesis. 1982;508-509.
15. Pettit G.R., Singh S.B., Cragg G.M. J. Org. Chem. 50:1985;3404-3406.
16. 3): δ 7.62 (d, 1H, J=15.3 Hz), 6.73 (s, 2H), 6.70 (d, 1H, J=15.3 Hz), 3.89 (s, 6H), 3.87 (s, 3H), 3.49 (q, 4H, J=7.1 Hz), 1.23 (br s, 6H).
17. Lawrence N.J., Ghani F.A., Hepworth L.A., Hadfield J.A., McGown A.T., Pritchard R.G. Synthesis. 9:1999;1656-1660.
18. Ramacciotti A., Fiaschi R., Napolitano E. Tetrahedron: Asymmetry. 7:1996;1101-1104.
19. Houk K.N., Sims J., Watts C.R., Luskus L.J. J. Am. Chem. Soc. 95:1973;7301-7315.
20. Syassi B., Bougrin K., Soufiaoui M. Tetrahedron Lett. 38:1997;8855-8858.
21. Weidner-Wells M.A., Fraga-Spano S.A., Turchi I.J. J. Org. Chem. 63:1998;6319-6328.
22. 3): δ 7.24 (dd, 1H, J=8.5, 2.1 Hz), 7.07 (d, 1H, J=2.1 Hz), 6.75 (d, 1H, J=8.5 Hz), 6.46 (s, 2H), 5.54 (d, 1H, J=5.7 Hz), 5.05 (d, 1H, J=5.7 Hz), 3.79 (s, 9H), 3.77 (s, 3H), 3.45 (m, 4H), 1.27 (t, 3H, J=7.0 Hz), 1.25 (t, 3H, J=7.0 Hz), 0.92 (s, 9H), 0.05 (s, 3H), 0.02 (s, 3H).
23. Bianchi G., De Micheli C., Gandolfi R., Grünanger P., Vita Finzi P. J. Chem. Soc., Perkin Trans. 1. 1973;1148-1155.
24. 5,4 is larger for isomer 3f (1.06) than for isomer 4f (0.49).
25. 13C NMR and mass data. Assessment of their ability to inhibit in vitro polymerization is now under investigation.
26. 24 With both dipolarophiles investigated, 2a and 2d, coupling was slightly more efficient (respective yields: 46% vs 38%, 11% vs 6%), probably due to a lesser steric hindrance. But the deprotecting step, realized with trifluoroacetic acid, was less effective. At last protection of the phenol function with a silyl group seems more effective.
27. Vlahov R., Krikorian D., Spassov G., Chinova M., Vlahov I., Parushev S., Snatzke G., Ernst L., Kieslich K., Abraham W.-R., Sheldrick W.S. Tetrahedron. 45:1989;3329-3345.